drugset / Trial / NCT06560515
Dinoprostone Versus Vaginal Misoprostol for Induction of Labour
RandomizedParallel-groupTriple-blindTreatment
Summary
This randomized controlled study was carried out on 370 pregnant women with gestational age ≥ 40 weeks of different ages and parities at El-Shatby Maternity University Hospital after approval of ethical committee of Alexandria Faculty of Medicine. After assessment for eligibility \& enrollment in the study, women were randomly assigned into one of the two study groups, Group (I) received 3 mg vaginal Dinoprostone of maximum 2 doses 6 hours apart and Group (II) received 50 μg of vaginal misoprostol of maximum 2 doses 6 hours apart.
Timeline
- Start
- 2022-08-01
- Primary completion
- 2023-07-31
- Completion
- 2023-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dinoprostone | Other / unclassified | 3 mg | Other |
Indications
No indication recorded.